Sign in
Taking people in United StatesNo phase

Testing Home Fetal Heart Monitoring for High-Risk Pregnancies

Tests a home device that checks baby's heart rate in high-risk pregnancies.

Key facts

Who runs it
Beth Israel Deaconess Medical Center
Where
Boston, United StatesSee the site
Trial code
Registry title
Remote Fetal Monitoring in High Risk Pregnancies
Status
Recruiting
People taking part
50 people, planned
Started
1 May 2025
Expected to end
1 Jan 2027
Type of study
Observational
Treatments tested
  • Fetal ECG monitoring
Record updated
9 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for pregnant women past 32 weeks with a high risk pregnancy who are asked by their obstetrician to have fetal testing at least once a week. They test fetal monitoring at home.

Age
18 years or older
Sex
Women only
Disease stage
High risk pregnancy, more than 32 weeks of pregnancy

Main reasons for not taking part

  • Under 18 years old
  • Does not speak English

This trial only enrols pregnant participants. The registry sentence this rests on: Intrauterine pregnancy greater than 32 weeks gestation

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Intrauterine pregnancy greater than 32 weeks gestation
  • Recommended for at least once weekly antenatal fetal testing by their obstetrician
  • English-speaking

Who cannot take part

  • Under age 18 years of old
  • Non-english speaking

Where in United States

  • Beth Israel Deaconess Medical CenterBoston, United StatesContact: Ethan Litman, MD,MSTaking people

About the trial

What the trial wants to find out

Antenatal nonstress tests (NSTs) are performed to assess fetal health and are used as a cost-effective test that can be widely administered. However, an NST is operator-dependent due to the nature of Doppler ultrasound and is primarily performed in a clinic and hospital setting.

Read full original descriptionShow less

The ability to conduct a clinically valuable test at home would address access to care issues faced by numerous women in the United States and reduce the workload on healthcare clinicians facing a shortage of human resources.

This pilot study aims to assess the feasibility and acceptability of home NST monitoring in order to determine whether femomTM could be utilized as an adjunct to routine prenatal care.

Patients with high risk pregnancies who are recommended to undergo at least once weekly at 32 weeks testing by the obstetrician will be recruited for participation in this study. Participants will be asked to perform three 30 minute monitoring sessions weekly starting at 32 weeks for 6 weeks.

The group in the trial

  • Remote Monitoring

    A cohort of patients with high risk pregnancies who will wear a remote monitoring device

    Treatment: Fetal ECG monitoring

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Investigating the Acceptability and Feasibility of Remote Fetal Monitoring in a High Risk Obstetric Population
Plain-language title
Testing Home Fetal Heart Monitoring for High-Risk PregnanciesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
9 March 2026